<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2023.1121399</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Oral microbial dysbiosis in patients with periodontitis and chronic obstructive pulmonary disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Siqin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2193449/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xie</surname>
<given-names>Guofang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Meifeng</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Yukun</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1734132"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Wenyi</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1734127"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Xiaobo</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mao</surname>
<given-names>Weigang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Nanxia</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yuanjie</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chang</surname>
<given-names>Qin</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiao</surname>
<given-names>Yingying</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Xinqian</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1734155"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xue</surname>
<given-names>Jianbo</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2135954"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jin</surname>
<given-names>Mengtong</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Guo</surname>
<given-names>Shuming</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hou</surname>
<given-names>Yudong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gao</surname>
<given-names>Zhancheng</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/709694"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Stomatology, Binzhou Medical University</institution>, <addr-line>Yantai</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Stomatology, Linfen Central Hospital</institution>, <addr-line>Linfen</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Respiratory and Critical Care Medicine, Linfen Central Hospital</institution>, <addr-line>Linfen</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Respiratory and Critical Care Medicine, Peking University People&#x2019;s hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Science and Education, Linfen Central Hospital</institution>, <addr-line>Linfen</addr-line>, <country>China</country>
</aff>
<aff id="aff6">
<sup>6</sup>
<institution>Nursing department, Linfen Central Hospital</institution>, <addr-line>Linfen</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Eva Maria Weissinger, Hannover Medical School, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Eija K&#xf6;n&#xf6;nen, University of Turku, Finland; Mustafa Yilmaz, Biruni University, T&#xfc;rkiye</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Shuming Guo, <email xlink:href="mailto:kyzx@linfench.com">kyzx@linfench.com</email>; Yudong Hou, <email xlink:href="mailto:bycgk@126.com">bycgk@126.com</email>; Zhancheng Gao, <email xlink:href="mailto:zcgao@bjmu.edu.cn">zcgao@bjmu.edu.cn</email>
</p>
</fn>
<fn fn-type="other" id="fn003">
<p>&#x2020;These authors share first authorship</p>
</fn>
<fn fn-type="equal" id="fn004">
<p>&#x2021;These authors have contributed equally to this work</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Microbiome in Health and Disease, a section of the journal Frontiers in Cellular and Infection Microbiology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>09</day>
<month>02</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>13</volume>
<elocation-id>1121399</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>12</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>30</day>
<month>01</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Liu, Xie, Chen, He, Yu, Chen, Mao, Liu, Zhang, Chang, Qiao, Ma, Xue, Jin, Guo, Hou and Gao</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Liu, Xie, Chen, He, Yu, Chen, Mao, Liu, Zhang, Chang, Qiao, Ma, Xue, Jin, Guo, Hou and Gao</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Oral microbiota is closely related to the homeostasis of the oral cavity and lungs. To provide potential information for the prediction, screening, and treatment strategies of individuals, this study compared and investigated the bacterial signatures in periodontitis and chronic obstructive pulmonary disease (COPD).</p>
</sec>
<sec>
<title>Materials and methods</title>
<p>We collected subgingival plaque and gingival crevicular fluid samples from 112 individuals (31 healthy controls, 24 patients with periodontitis, 28 patients with COPD, and 29 patients with both periodontitis and COPD). The oral microbiota was analyzed using 16S rRNA gene sequencing and diversity and functional prediction analysis were performed.</p>
</sec>
<sec>
<title>Results</title>
<p>We observed higher bacterial richness in individuals with periodontitis in both types of oral samples. Using LEfSe and DESeq2 analyses, we found differentially abundant genera that may be potential biomarkers for each group. <italic>Mogibacterium</italic> is the predominant genus in COPD. Ten genera, including <italic>Desulfovibrio</italic>, <italic>Filifactor</italic>, <italic>Fretibacterium, Moraxella, Odoribacter, Pseudoramibacter Pyramidobacter, Scardovia, Shuttleworthia</italic> and <italic>Treponema</italic> were predominant in periodontitis. <italic>Bergeyella, Lautropia, Rothia, Propionibacterium</italic> and <italic>Cardiobacterium</italic> were the signature of the healthy controls. The significantly different pathways in the Kyoto Encyclopedia of Genes and Genomes (KEGG) between healthy controls and other groups were concentrated in genetic information processing, translation, replication and repair, and metabolism of cofactors and vitamins.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>We found the significant differences in the bacterial community and functional characterization of oral microbiota in periodontitis, COPD and comorbid diseases. Compared to gingival crevicular fluid, subgingival plaque may be more appropriate for reflecting the difference of subgingival microbiota in periodontitis patients with COPD. These results may provide potentials for predicting, screening, and treatment strategies for individuals with periodontitis and COPD.</p>
</sec>
</abstract>
<kwd-group>
<kwd>periodontal disease</kwd>
<kwd>COPD</kwd>
<kwd>oral microbiome</kwd>
<kwd>16S rRNA</kwd>
<kwd>subgingival plaque</kwd>
<kwd>gingival crevicular fluid</kwd>
<kwd>inflammation</kwd>
<kwd>chronic obstructive pulmonary disease</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="51"/>
<page-count count="11"/>
<word-count count="5143"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The oral microenvironment is complicated and comprises more than 700 bacterial species (<xref ref-type="bibr" rid="B13">Dewhirst et&#xa0;al., 2010</xref>). Among them, 400 species have been identified in periodontal pockets. Oral microbial dysbiosis is known to impact chronic inflammatory diseases (<xref ref-type="bibr" rid="B44">Thomas et&#xa0;al., 2021</xref>). Microbial migration from the oral cavity appears to be a significant source of the lung microbiome through microaspiration and inhalation (<xref ref-type="bibr" rid="B3">Bassis et&#xa0;al., 2015</xref>). Thus, the oral microbiota is closely related to the homeostasis of the oral cavity and lungs.</p>
<p>Periodontitis , a chronic infectious disease caused by periodontal pathogens, is characterized by the loss of gingiva, bone, and ligament and deep periodontal pockets between the tooth and gingiva (<xref ref-type="bibr" rid="B24">Kinane et&#xa0;al., 2017</xref>). Periodontitis is a highly prevalent oral disease in China, with a prevalence of up to 52.8% (<xref ref-type="bibr" rid="B23">Jiao et&#xa0;al., 2021</xref>). Emerging evidence has revealed that periodontitis is closely related to the oral microbiota, which can increase the risk of the development of chronic inflammatory conditions, thereby leading to coronary artery disease, systemic lupus erythematosus, and respiratory disease (<xref ref-type="bibr" rid="B17">Gomes-Filho et&#xa0;al., 2010</xref>; <xref ref-type="bibr" rid="B37">Preshaw et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B42">Slocum et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B28">Li et&#xa0;al., 2020</xref>). Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases characterized by progressive and non-reversible airflow limitation (<xref ref-type="bibr" rid="B1">Barnes et&#xa0;al., 2015a</xref>). Recurrent episodes of exacerbations in COPD lead to significant mortality worldwide (<xref ref-type="bibr" rid="B2">Barnes et&#xa0;al., 2015b</xref>; <xref ref-type="bibr" rid="B7">Caramori et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B38">Rabe and Watz, 2017</xref>). Disturbed lung microbiome and abnormal inflammatory reactions are the two main causes of acute exacerbation of COPD (<xref ref-type="bibr" rid="B34">Mammen and Sethi, 2016</xref>).</p>
<p>Gram-negative bacteria, such as <italic>Porphyromonas gingivalis</italic>, <italic>Treponema denticola</italic>, and species are believed to be the main oral microbiome in the periodontal inflammatory response (<xref ref-type="bibr" rid="B15">Gaeckle et&#xa0;al., 2020</xref>). Compared with the control group, the abundance of <italic>P.gingivalis</italic>, <italic>Klebsiella pneumoniae</italic>, <italic>Pseudomonas aeruginosa</italic> and <italic>Streptococcus pneumoniae</italic> increased in participants with COPD (<xref ref-type="bibr" rid="B43">Tan et&#xa0;al., 2019</xref>). Moreover, <italic>Veillonella</italic>, <italic>Rothia</italic>, and <italic>Actinomyces</italic> were more enriched in patients with COPD and periodontitis than in HCs(<xref ref-type="bibr" rid="B29">Lin et&#xa0;al., 2020</xref>). Treating periodontitis significantly reduced exacerbation frequency in patients with COPD (<xref ref-type="bibr" rid="B25">Kucukcoskun et&#xa0;al., 2013</xref>). Although most recent studies have explored the relationship and influence mechanism of periodontitis or COPD, research on the alteration of the oral microbiome in patients with periodontitis, COPD or both, remains insufficient. Moreover, previous studies have mainly focused on saliva samples; however, the bacterial composition differs between saliva and subgingival pockets (<xref ref-type="bibr" rid="B21">Jakubovics and Kolenbrander, 2010</xref>; <xref ref-type="bibr" rid="B22">Jia et&#xa0;al., 2018</xref>). As the main accumulation site of periodontal pathogens, subgingival plaque more directly reflects the status of the subgingivalmicrobiome.</p>
<p>In this study, we investigated the shared and specific alterations in the oral microbiomes of participants with periodontitis, COPD, or both, through 16S rRNA gene sequencing.</p>
</sec>
<sec id="s2" sec-type="material|methods">
<label>2</label>
<title>Material and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Study participants</title>
<p>The present study was approved by the ethics committee of Linfen Central Hospital (Ethics Approval No. 2021-42-1) and was performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to clinical data collection and sampling.</p>
<p>A total of 112 participants were recruited at Linfen Central Hospital, including 31 healthy controls (HC group), 24 periodontitis patients without COPD (P group), 28 COPD patients without periodontitis(COPD group), and 29 patients with both periodontitis and COPD(P_COPD group). The diagnosis and assessment of the severity of COPD were made according to the recommendations of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) committee (<xref ref-type="bibr" rid="B46">Vogelmeier et&#xa0;al., 2017</xref>). The diagnosis and assessment of the periodontitis were based on the new classification, Classification of Periodontal and Peri-implant Diseases and Conditions (<xref ref-type="bibr" rid="B45">Tonetti et&#xa0;al., 2018</xref>). Other inclusion criteria included: (1) aged &#x2265;18 years; and (2) Periodontitis from stage II to IV, grade B. The exclusion criteria were antibiotic using before during the last three months, other systemic diseases, administration of periodontal therapy during the last three months (<xref ref-type="bibr" rid="B5">Cai et&#xa0;al., 2021</xref>). General participant demographics, including age, gender, blood routine records, pulmonary function test results and clinical treatments were collected from medical record system using a standard form.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Sample collection</title>
<p>Before sample collection, the participants were asked to rinse their mouth for removing the food residues and debris. We obtained oral samples from four first incisor teeth and four first molar teethof each participant. The first molars and incisors are the main sites of periodontal lesions, and we selected 11, 21, 31, 41, 16, 26, 36, 46 as the main sampling sites based on previous periodontal microbiology studies (<xref ref-type="bibr" rid="B50">Zhou et&#xa0;al., 2020</xref>). Clinical examination was performed before sampling to ensure that the sampling site clinical attachment loss (CAL) &#x2265; 3mm, probing depth (PD) &#x2265; 4mm and bleeding on probing. If one of these teeth was missing, the adjacent tooth was collected. After drying the target sites, gingival crevicular fluid (GCF) samples were collected with sterile absorbent paper points from gingival sulcus of each tooth. After removal of supragingival plaque, subgingival plaque (SP) samples were collected with sterile Gracey curettes from the buccal and lingual sides of each tooth. The sample of each participant was collected in the eppendorf tube. All oral specimens (subgingival plaque and gingival crevicular fluid) were stored in -80&#xb0;C until DNA extraction.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>DNA extraction, 16S rRNA gene amplification, and sequencing</title>
<p>Total bacterial DNA was extracted from oral samples using SteadyPure Bacterial Genomic DNA Extraction Kit(Accurate Biotechnology(Hunan)Co,Ltd,China) following the manufacturer&#x2019;s instructions. Hypervariable regions (V2, V3, V4, V6-7, V8 and V9) of the 16S rRNA were amplified using two primer sets in the Ion 16STM Metagenomics Kit (ThermoFisher Scientific, UK). XP beads were used to purify the amplification products and quantified by Qubit4 (ThermoFisher Scientific, USA). Purified amplicons were ligated with barcodes and then generated for the libraries. Then the libraries were pooled in equimolar amounts on chip 530 and sequenced to single-end, 250-base-pair reads on an Ion GeneStudio S5 System (ThermoFisher Scientific, USA) based on Ion Reporter metagenomics workflow (Ion 16S mNGS). Quality filtering, trimming and dereplication of raw sequencing reads were conducted automatically on Ion Reporter metagenomics workflow, relying on default parameters. Unaligned binary data files (Binary Alignment Map, BAM) generated by the Ion Torrent PGM were uploaded to Ion Reporter and analyzed using default settings (<xref ref-type="bibr" rid="B33">Malczynski et&#xa0;al., 2021</xref>).</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>Statistical analysis</title>
<p>Quantitative variables conforming to normal distribution were presented as the mean &#xb1; SD analyzed by Student&#x2019;s t test and analysis of variance (ANOVA), while Quantitative variables of non-normal distribution were presented as median and interquartile ranges (25th and 75th percentiles) and analyzed by Mann-Whitney U or Kruskal-Wallis test. Categorical variables were presented as rate or percentage, and chi-square test or Fisher test were used to analysis. The alpha diversity was evaluated using the Chao-1, Shannon, abundance-based coverage estimator (ACE) and Simpson indices, respectively. The beta diversity has been evaluated through principal coordinates analysis (PCoA) ordination of variance and compared using Bray-Curtis dissimilarity. Differential species among groups was explored with the linear discriminant analysis (LDA) effect size (LEfSe) method (<xref ref-type="bibr" rid="B40">Shi et&#xa0;al., 2021</xref>) and DESeq2 analysis (<xref ref-type="bibr" rid="B30">Lu et&#xa0;al., 2022</xref>). The microbiome phenotypes were predicted by BugBase (<xref ref-type="bibr" rid="B47">Ward et&#xa0;al., 2017</xref>). The BugBase phenotype predictions were implemented using the online web page <uri xlink:href="https://bugbase.cs.umn.edu/index.html">https://bugbase.cs.umn.edu/index.html</uri>. Prediction of the abundances of functional categories was conducted using PICRUSt2 (<xref ref-type="bibr" rid="B14">Douglas et&#xa0;al., 2020</xref>). Statistics and visualization of functional data were depicted using STAMP (<xref ref-type="bibr" rid="B8">Chowdhry et&#xa0;al., 2018</xref>). <italic>P</italic>&lt;0.05 was considered as statistically significant.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>Clinical characteristics of the study population</title>
<p>A total of 112 participants were enrolled in our study, and the basic characteristics of each group are listed in <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref>. There were no differences among the groups except for gender, age and smoking. The healthy control (HC) group&#x2019;s median age was significantly younger than the diseased groups. The median age of the comorbid (P_COPD) group was highest. Moreover, the healthy group had a higher proportion of female participants. Significant difference of smoking was only existed between healthy control group and periodontitis group. Gender, age and smoking status were treated as confounding factors which were corrected in the difference analysis(<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S4A</bold>
</xref>). There were no significant differences in the GOLD grade and clinical indicators between the COPD and P_COPD groups.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Demographical and Clinical Features of Included Subjects.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" align="left"/>
<th valign="bottom" align="center">HC(n=31)</th>
<th valign="bottom" align="center">P(n=24)</th>
<th valign="bottom" align="center">COPD(n=28)</th>
<th valign="bottom" align="center">P_COPD(n=29)</th>
<th valign="bottom" align="center">
<italic>p</italic>-value</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="left">Age</td>
<td valign="bottom" align="center">25(23-38)</td>
<td valign="bottom" align="center">53.5(47.25-61.25)</td>
<td valign="bottom" align="center">61(51.75-67.75)</td>
<td valign="bottom" align="center">66(60.5-72.5)</td>
<td valign="bottom" align="center">&lt;0.005<sup>a</sup>
</td>
</tr>
<tr>
<td valign="bottom" align="left">Gender,n (%)</td>
<td valign="bottom" align="left"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center">&lt;0.001<sup>b</sup>
</td>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;female</td>
<td valign="bottom" align="center">19(61.3%)</td>
<td valign="bottom" align="center">9(37.5%)</td>
<td valign="bottom" align="center">5(17.9%)</td>
<td valign="bottom" align="center">4(13.8%)</td>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;male</td>
<td valign="bottom" align="center">12(38.7%)</td>
<td valign="bottom" align="center">15(62.5%)</td>
<td valign="bottom" align="center">23(82.1%)</td>
<td valign="bottom" align="center">25(86.2%)</td>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">Somkers,n (%)</td>
<td valign="bottom" align="left"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;Current smoker</td>
<td valign="bottom" align="center">3(9.7%)</td>
<td valign="bottom" align="center">12(50%)</td>
<td valign="bottom" align="center">7(25%)</td>
<td valign="bottom" align="center">7(24.1%)</td>
<td valign="bottom" align="center">&lt;0.001<sup>c</sup>
</td>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;Former smoker</td>
<td valign="bottom" align="center">0</td>
<td valign="bottom" align="center">0</td>
<td valign="bottom" align="center">7(25%)</td>
<td valign="bottom" align="center">15(51.7%)</td>
<td valign="bottom" align="center">&gt;0.05</td>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;Nonsmoker</td>
<td valign="bottom" align="center">28(90.3%)</td>
<td valign="bottom" align="center">12(50%)</td>
<td valign="bottom" align="center">14(50%)</td>
<td valign="bottom" align="center">7(24.1%)</td>
<td valign="bottom" align="center">&lt;0.001<sup>d</sup>
</td>
</tr>
<tr>
<td valign="bottom" align="left">PD(mm)</td>
<td valign="top" align="center">2(1-2)</td>
<td valign="top" align="center">6.33(4.33-6.92)</td>
<td valign="top" align="center">2(1.25-2)</td>
<td valign="top" align="center">6.33(5-6.67)</td>
<td valign="bottom" align="center">&lt;0.001<sup>e</sup>
</td>
</tr>
<tr>
<td valign="bottom" align="left">BOP%</td>
<td valign="top" align="center">2.08(2.08-4.17)</td>
<td valign="top" align="center">78.13(71.35-83.33)</td>
<td valign="top" align="center">2.08(2.08-4.17)</td>
<td valign="top" align="center">81.25(68.75-87.5)</td>
<td valign="bottom" align="center">&lt;0.001<sup>f</sup>
</td>
</tr>
<tr>
<td valign="bottom" align="left">Stage(%)</td>
<td valign="bottom" align="left"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center">0.612</td>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;II</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">9(37.5%)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">8(27.6%)</td>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;III</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="top" align="center">10(41.7%)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">16(55.2%)</td>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;IV</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="top" align="center">5(20.8%)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">5(17.2%)</td>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">GOLD(%)</td>
<td valign="bottom" align="left"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center"/>
<td valign="bottom" align="center">0.712</td>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;I</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">3(10.7%)</td>
<td valign="bottom" align="center">6(20.7%)</td>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;II</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">11(39.3%)</td>
<td valign="bottom" align="center">10(34.5%)</td>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;III</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">9(32.1%)</td>
<td valign="bottom" align="center">7(24.1%)</td>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">&#x2003;IV</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">5(17.9%)</td>
<td valign="bottom" align="center">6(20.7%)</td>
<td valign="bottom" align="center"/>
</tr>
<tr>
<td valign="bottom" align="left">BMI(kg/m<sup>2</sup>)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">27.35(23.43-29.3)</td>
<td valign="bottom" align="center">23.5(22.1-25.75)</td>
<td valign="bottom" align="center">0.007</td>
</tr>
<tr>
<td valign="bottom" align="left">FVC(L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">2.88(2.51-3.56)</td>
<td valign="bottom" align="center">2.82(2.34-3.67)</td>
<td valign="bottom" align="center">0.943</td>
</tr>
<tr>
<td valign="bottom" align="left">FEV1(L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">1.43(0.99-2.18)</td>
<td valign="bottom" align="center">1.34(0.92-2.12)</td>
<td valign="bottom" align="center">0.472</td>
</tr>
<tr>
<td valign="bottom" align="left">FEV1%</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">58.31(35.71-73.54)</td>
<td valign="bottom" align="center">53.08(33.56-75.52)</td>
<td valign="bottom" align="center">0.576</td>
</tr>
<tr>
<th valign="bottom" colspan="6" align="left">Peripheral blood</th>
</tr>
<tr>
<td valign="bottom" align="left">WBC(x10<sup>9</sup>/L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">6.3 &#xb1; 2.1</td>
<td valign="bottom" align="center">6.5 &#xb1; 1.7</td>
<td valign="bottom" align="center">0.675</td>
</tr>
<tr>
<td valign="bottom" align="left">RBC(x10<sup>12</sup>/L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">4.7 &#xb1; 0.4</td>
<td valign="bottom" align="center">4.7 &#xb1; 0.4</td>
<td valign="bottom" align="center">0.797</td>
</tr>
<tr>
<td valign="bottom" align="left">HGB(g/L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">143.4 &#xb1; 11.2</td>
<td valign="bottom" align="center">142.8 &#xb1; 12.1</td>
<td valign="bottom" align="center">0.848</td>
</tr>
<tr>
<td valign="bottom" align="left">Neutrophil percentages(%)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">57.2 &#xb1; 8.1</td>
<td valign="bottom" align="center">58.6 &#xb1; 10.4</td>
<td valign="bottom" align="center">0.578</td>
</tr>
<tr>
<td valign="bottom" align="left">Lymphocyte percentages(%)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">31.1 &#xb1; 6.7</td>
<td valign="bottom" align="center">30.5 &#xb1; 9.9</td>
<td valign="bottom" align="center">0.799</td>
</tr>
<tr>
<td valign="bottom" align="left">Monocytes percentages(%)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">7.5(6.45-10)</td>
<td valign="bottom" align="center">7.7(6.65-9)</td>
<td valign="bottom" align="center">0.958</td>
</tr>
<tr>
<td valign="bottom" align="left">Eosinophil percentages(%)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">2.3(1.45-3.85)</td>
<td valign="bottom" align="center">2.3(1.25-2.85)</td>
<td valign="bottom" align="center">0.409</td>
</tr>
<tr>
<td valign="bottom" align="left">Basophil percentages(%)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">0.5 &#xb1; 0.3</td>
<td valign="bottom" align="center">0.5 &#xb1; 0.2</td>
<td valign="bottom" align="center">0.706</td>
</tr>
<tr>
<td valign="bottom" align="left">Neutrophil(x10<sup>9</sup>/L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">2.99(2.62-5.125)</td>
<td valign="bottom" align="center">3.8(2.675-4.67)</td>
<td valign="bottom" align="center">0.482</td>
</tr>
<tr>
<td valign="bottom" align="left">Lymphocyte(x10<sup>9</sup>/L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">1.9 &#xb1; 0.5</td>
<td valign="bottom" align="center">2.0 &#xb1; 0.7</td>
<td valign="bottom" align="center">0.719</td>
</tr>
<tr>
<td valign="bottom" align="left">Monocytes(x10<sup>9</sup>/L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">0.43(0.375-0.565)</td>
<td valign="bottom" align="center">0.54(0.48-0.615)</td>
<td valign="bottom" align="center">0.147</td>
</tr>
<tr>
<td valign="bottom" align="left">Eosinophil(x10<sup>9</sup>/L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">0.15(0.08-0.22)</td>
<td valign="bottom" align="center">0.12(0.08-0.205)</td>
<td valign="bottom" align="center">0.567</td>
</tr>
<tr>
<td valign="bottom" align="left">Basophil (x10<sup>9</sup>/L)</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">&#x2014;</td>
<td valign="bottom" align="center">0.03(0.02-0.04)</td>
<td valign="bottom" align="center">0.03(0.02-0.05)</td>
<td valign="bottom" align="center">0.333</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>
<sup>a</sup>Significant difference exists among healthy control group and other groups, significant difference exists between periodontitis group and COPD with periodontitis group.</p>
</fn>
<fn>
<p>
<sup>b</sup>Significant differences exists among healthy control group and other three groups.</p>
</fn>
<fn>
<p>
<sup>c,d</sup>Significant difference exists between healthy control group and periodontitis group.</p>
</fn>
<fn>
<p>
<sup>e,f</sup>Significant difference exists between healthy control group and periodontitis group, significant difference exists between COPD group and periodontitis group, significant difference exists between COPD group and COPD with periodontitis group.</p>
</fn>
<fn>
<p>BMI, body mass index; GOLD, grading of pulmonary function; WBC, white blood cell; RBC, red blood cell; PD, probing depth; BOP, bleeding on probing.</p>
</fn>
<fn>
<p>HC, health controls; P, patients with periodontitis; COPD, patients with chronic obstructive pulmonary disease; P_COPD, patients with comorbid diseases.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>The oral microbial community in the periodontal pocket and crevice</title>
<p>All sequencing data for the four groups reached saturation at approximately 50,000 reads (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S1</bold>
</xref>). For alpha diversity, the Chao1 index in the subgingival plaque (SP) samples from the periodontitis group was significantly higher than that in the HC group (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>, <italic>P</italic> = 0.0245). In the gingival crevicular fluid (GCF) samples, the Chao1 index of periodontitis group was significantly higher than that of the COPD group (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>, <italic>P</italic> = 0.0068) and P_COPD group (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>, <italic>P</italic> = 0.0063). However, no significant difference was found in the Shannon, Simpson and ACE indices among the four groups in the different sample types (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1A, C</bold>
</xref>, <italic>P</italic> &gt; 0.05). To evaluate similarities among the four groups, PCoA was based on unweighted UniFrac distances. Regardless of the SP or GCF samples, beta diversity was different in the HC and diseased groups (<xref ref-type="fig" rid="f1">
<bold>Figures&#xa0;1B, D</bold>
</xref>). However, in the SP samples, the bacterial compositions in the periodontitis, COPD, and P_COPD groups were indistinguishable (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>, <italic>P</italic>&gt;0.05). For the GCF samples, beta diversity was different between theperiodontitis and P_COPD groups (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Alpha diversity analysis of healthy controls (HC), periodontitis (P) group, chronic obstructive pulmonary disease (COPD) group and comorbid diseases (P_COPD) group. Chao1, Shannon, abundance-based coverage estimator (ACE) and Simpson indices of each group, <bold>(A)</bold> in subgingival plaque samples and <bold>(C)</bold> in gingival crevicular fluid samples. Under Chao1 index, significant difference between HC and P was observed in subgingival plaque samples, significant differences between P and COPD, P and P_COPD were observed in gingival crevicular fluid samples. Principal coordinate analysis (PCoA) among healthy controls (HC), periodontitis (P) group, chronic obstructive pulmonary disease (COPD) group and comorbid diseases (P_COPD) group. <bold>(B)</bold> The PCoA plot showed a separation of samples from HC and other diseased groups in subgingival plaque samples. <bold>(D)</bold> The PCoA plot showed a separation of samples from HC and other diseased groups in gingival crevicular fluid samples. The samples of P_COPD were separated from P group.*: <italic>p</italic> &lt; 0.05 **: <italic>p</italic> &lt; 0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1121399-g001.tif"/>
</fig>
<p>Eight phyla, 50 families, 98 genera were detected in the SP samples. The most abundant genera were <italic>Prevotella</italic>, <italic>Corynebacterium, Capnocytophaga</italic>, <italic>Fusobacterium</italic>, <italic>Streptococcus and Porphyromonas</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). <italic>Actinomyces</italic>, <italic>Campylobacter, Capnocytophaga</italic>, <italic>Neisseria</italic>, <italic>Prevotella</italic> and <italic>Streptococcus</italic> were present in all SP samples (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). Nine phyla, 57 families and 118 genera were identified in the GCF samples. The most abundant genera were <italic>Streptococcus</italic>, <italic>Prevotella</italic>, <italic>Fusobacterium</italic>, <italic>Porphyromonas</italic>, <italic>Neisseria</italic> and <italic>Capnocytophaga</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). The core microbiota of the GCF samples were <italic>Actinomyces</italic>, <italic>Campylobacter</italic>, <italic>Fusobacterium</italic>, <italic>Leptotrichia</italic>, <italic>Porphyromonas</italic>, <italic>Prevotella</italic>, <italic>Streptococcus</italic> and <italic>Tannerella</italic> (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2D</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Relative abundances of the oral microbiota in healthy controls (HC), periodontitis (P) group, chronic obstructive pulmonary disease (COPD) group and comorbid diseases (P_COPD) group. Stacked bar plots showing relative abundances of the oral microbiota at the genus level <bold>(A)</bold> in subgingival plaque samples, <bold>(C)</bold> in gingival crevicular fluid samples. The correlation network analysis of the core microbiota based on SparCC. The core microbiota was defined as which covering 100% of all samples. <bold>(B)</bold> In subgingival plaque samples. <bold>(D)</bold> In gingival crevicular fluid samples.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1121399-g002.tif"/>
</fig>
<p>In periodontitis group, we explored the differential taxa among stages of periodontitis. In both types of oral samples, no significant difference was found in the alpha diversity analysis and beta diversity analysis among the different stages of periodontitis. There were no difference in the taxa among stages of periodontitis (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S4B, S4C</bold>
</xref>, <italic>P</italic> &gt; 0.05).</p>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Microbial alterations in different diseases</title>
<p>To further identify the differential taxa among these groups, LEfSe and DESeq2 analyses were conducted. According to the LEfSe analysis, in the SP samples, eight genera were predominant in the HC group, including <italic>Actinomyces</italic>, <italic>Bergeyella</italic>, <italic>Brachymonas</italic>, <italic>Cardiobacterium</italic>, <italic>Lautropia</italic>, <italic>Mannheimia</italic>, <italic>Propionibacterium</italic> and <italic>Rothia</italic>. In contrast, the abundance of <italic>Haemophilus</italic>, <italic>Filifactor</italic>, and <italic>Moraxella</italic> increased in the periodontitis group. The abundance of <italic>Atopobium</italic> and <italic>Lachnoanaerobaculum</italic> were higher in the COPD group and the abundance of <italic>Stomatobaculum</italic>, <italic>Anaeroglobus</italic>, <italic>Bifidobacterium</italic>, and <italic>Clostridium</italic> were higher in the P_COPD group. (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>, LDA score (log10) &gt;2, <italic>P</italic> &lt; 0.05). According to DESeq2 analysis (<xref ref-type="supplementary-material" rid="SM1">
<bold>Table S1</bold>
</xref>), there were significant differences in the oral microbiota of the three diseased groups in the SP samples but no common change among these groups. Twenty-nine genera were predominant in the periodontitis group, including <italic>Filifactor</italic>, <italic>Mogibacterium</italic>, <italic>Scardovia</italic>, <italic>Murdochiella</italic> and <italic>Odoribacter. Abiotrophia</italic> and <italic>Gemella</italic> were more abundant in the COPD group and the abundance of <italic>Cardiobacterium</italic> was higher in the P_COPD group. The abundance of <italic>Bergeyella</italic> decreased in the periodontitis and COPD groups. The abundance of <italic>Pasteurella</italic> and <italic>Propionicicella</italic> decreased in the periodontitis group. The abundance of <italic>Desulfobulbus</italic>, <italic>Soonwooa</italic> and <italic>Johnsonella</italic> decreased in the COPD group (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>).</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Linear discriminant analysis of effect size (LEfSe) of oral microbiota at the genus level enriched in healthy controls (HC), periodontitis (P) group, chronic obstructive pulmonary disease (COPD) group and comorbid diseases (P_COPD) group. LDA score (log10) &lt;2, <italic>P</italic> &lt; 0.05) <bold>(A)</bold> In subgingival plaque samples. <bold>(C)</bold> In gingival crevicular fluid samples. DESeq2 analysis of oral microbiota. Oral microbiota with significantly difference from the diseased groups compared with healthy controls <bold>(B)</bold> in subgingival plaque samples, <bold>(D)</bold> in gingival crevicular fluid samples. * The relative abundances of <italic>Phocaeicola</italic> was more abundant in CP group, while the relative abundance of <italic>Phocaeicola</italic> in COPD group was lower than HC groups. &#x2193;, decreased. Spearman&#x2019;s coefficient calculated between oral microbiota and clinical indicators. The taxa analyzed were the top 20 genera in terms of abundance <bold>(E)</bold> in subgingival plaque samples, <bold>(F)</bold> in gingival crevicular fluid samples. Black stars within heatmap boxes indicate significant results (*: <italic>P</italic> &#x2264; 0.05, **: <italic>P</italic> &#x2264;0 .01), Benjamini&#x2013;Hochberg adjustment for multiple comparisons.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1121399-g003.tif"/>
</fig>
<p>According to LEfSe analysis, in the GCF samples, the abundance of eight genera: <italic>Bergeyella</italic>, <italic>Cardiobacterium</italic>, <italic>Kingella</italic>, <italic>Lautropia</italic>. <italic>Propionibacterium</italic>, <italic>Rothia</italic>, <italic>Serratia</italic> and <italic>Staphylococcus</italic> were more abundant in the HC group. <italic>Desulfovibrio</italic>, <italic>Dorea</italic>, <italic>Filifactor</italic>, <italic>Fretibacterium</italic>, <italic>Moraxella</italic>, <italic>Pseudoramibacter</italic> and <italic>Treponema</italic> were more abundant in the P group, while the abundance of <italic>Mogibacterium</italic> increased in the COPD group. The abundance of <italic>Phocaeicola</italic> and <italic>Schwartzia</italic> was higher in the P_COPD group. (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>, LDA score (log10) &gt;2, <italic>P</italic> &lt; 0.05). According to DESeq2 analysis (<xref ref-type="supplementary-material" rid="SM1">
<bold>Table S2</bold>
</xref>), there were significant differences in the oral microbiota of the three diseased groups, but no common changes were observed among these groups. Fifteen genera were predominant in the periodontitis group: <italic>Pasteurella</italic>, <italic>Phocaeicola</italic>, <italic>Pseudoramibacter</italic>, <italic>Pseudoramibacte</italic>r, <italic>Pyramidobacter</italic>, <italic>Scardovia</italic>, <italic>Schwartzia</italic>, <italic>Shuttleworthia</italic>, <italic>Slackia</italic>, <italic>Stomatobaculum</italic> and <italic>Synergistes</italic>. The abundance of <italic>Corynebacterium</italic>, <italic>Bacillus</italic>, <italic>Ottowia</italic> and <italic>Neisseria</italic> decreased in the periodontitis group. The abundance of <italic>Serratia</italic> decreased in the COPD group. The abundance of <italic>Kingella</italic>, <italic>Alloprevotella</italic> and <italic>Dialister</italic> decreased in the P_COPD group (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3D</bold>
</xref>).</p>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Association between genera and blood routine indicators</title>
<p>The observed links between the respiratory microbial community and disease prompted us to examine the interactions between the taxa and their clinical features. The taxa analyzed were the top 20 genera regarding abundance. For SP samples, the relative abundance of <italic>Streptococcus</italic> was negatively correlated with neutrophil, white blood cell and monocyte counts. The relative abundance of <italic>Rothia</italic> was negatively correlated with lymphocyte counts. The relative abundance of L<italic>eptotrichia</italic> and <italic>Campylobacter</italic> were positively correlated with the basophil counts, and the relative abundance of <italic>Aggregatibacter</italic> and <italic>Neisseria</italic> were negatively correlated with the basophil counts (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3E</bold>
</xref>). In the GCF samples, the relative abundance of <italic>Rothia</italic>, <italic>Streptococcus</italic>, and <italic>Haemophilus</italic> was positively correlated with the lymphocyte percentages. The relative abundance of <italic>Streptococcus</italic> and <italic>Rothia</italic> was negatively correlated with the neutrophil percentages, and the relative abundance of <italic>Veillonella</italic> was positively correlated with neutrophil percentages. The relative abundance of <italic>Treponema</italic> was positively correlated with neutrophil counts. In addition, the relative abundance of <italic>Leptotrichia</italic> was negatively correlated with the eosinophil percentages (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3F</bold>
</xref>).</p>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Potential function of oral microbiome</title>
<p>We analyzed the predicted phenotypes based on taxonomic classification using BugBase. In different sample types, the relative abundance of aerobic bacteria in the HC group was higher than that in the diseased groups (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2A</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>S2F</bold>
</xref>). In comparison, the relative abundance of anaerobic bacteria was lower in the HC group than that in the diseased groups (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>S2G</bold>
</xref>). The ability to form biofilms in the HC group was greater than that in the diseased groups (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2C</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>S2H</bold>
</xref>). The potential pathogenicity in the HC group was lower than that in the diseased groups in the SP samples (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2D</bold>
</xref>). In the GCF samples, the potential pathogenicity in the P group was lower than that in the other groups (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S2I</bold>
</xref>). In addition, in the SP samples, the relative abundance of gram-positive bacteria in the HC group was higher than that in the other diseased groups, whereas gram-negative bacteria showed the opposite trend (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figures S2E</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>S2J</bold>
</xref>).</p>
<p>Through PICRUSt2, putative biological functions of the microbiota of the four groups were illustrated. No significant differences were observed between the GCF samples. As shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>, the periodontitis group exhibited significantly enriched metabolism of cofactors and vitamins (thiamine metabolism, nicotinate and nicotinamide metabolism), translation, protein families: genetic information processing (translation factors), amino acid related enzymes, and carbon fixation in photosynthetic organisms. The COPD group showed significantly enriched protein families: genetic information processing (transfer RNA biogenesis, ribosome, mitochondrial biogenesis, DNA replication proteins, translation factors), translation (ribosome, aminoacyl-tRNA biosynthesis, RNA transport), replication and repair (homologous recombination, mismatch repair, DNA replication), protein families: metabolism (peptidases and inhibitors, amino acid related enzymes, peptidoglycan biosynthesis and degradation proteins), glycan biosynthesis and metabolism(peptidoglycan biosynthesis, other glycan degradation, other types of O-glycan biosynthesis and mannose type O-glycan biosynthesis) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). The P_COPD group showed significantly enriched protein families: genetic information processing (DNA repair and recombination proteins, transfer RNA biogenesis, ribosome, chromosome and associated proteins), protein families: metabolism (amino acid related enzymes, peptidases and inhibitors, peptidoglycan biosynthesis and degradation proteins), translation (ribosome, aminoacyl-tRNA biosynthesis, RNA transport), glycan biosynthesis and metabolism(peptidoglycan biosynthesis, other glycan degradation, lipopolysaccharide biosynthesis), metabolism of cofactors and vitamins(lipoic acid metabolism, porphyrin and chlorophyll metabolism, riboflavin metabolism, thiamine metabolism) and other functions (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>PICRUSt analysis in the KEGG pathways. Functional predictions for the oral microbiome of the diseased groups and healthy control group. Significant KEGG pathways at level 3 for the oral microbiome of the diseased groups and healthy control group in subgingival plaque samples were identified by STAMP software. Bar chart showing the functional difference (corrected <italic>p</italic>-value &lt; 0.05) between periodontitis <bold>(A)</bold>, chronic obstructive pulmonary disease <bold>(B)</bold> and comorbid diseases <bold>(C)</bold> versus healthy controls. PICRUSt, Phylogenetic Investigation of Communities by Reconstruction of Unobserved States; KEGG, Kyoto Encyclopedia of Genes and Genomes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-13-1121399-g004.tif"/>
</fig>
<p>The HC group showed significantly enriched signal transduction (two-component system), lipid metabolism (biosynthesis of unsaturated fatty acids), and metabolism of other amino acids (glutathione metabolism, phosphonate and phosphinate metabolism), compared to the other three groups (<xref ref-type="supplementary-material" rid="SM1">
<bold>Figure S3</bold>
</xref>).</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>The alteration of oral microecosystem in patients with systemic diseases has been the subject of intense research for several years (<xref ref-type="bibr" rid="B44">Thomas et&#xa0;al., 2021</xref>). An increasing amount of evidence from microbiological studies indicates a significant ecological connection between oral microecosystems, periodontitis and COPD (<xref ref-type="bibr" rid="B48">Wu et&#xa0;al., 2022</xref>). Here we explored the oral microbiota of SP and GCF in periodontitis, COPD, comorbid patients, and healthy controls. In this study, we collected oral microbial samples of two types. Compared with the GCF, differences in the microbial community compositions of SP more clearly expressed the varieties of oral microecology in periodontitis and COPD, indicating that it may be more appropriate for reflecting the difference of subgingival microbiota between periodontitis and COPD.</p>
<p>This study observed higher bacterial richness in individuals suffering from periodontitis in the two types of oral samples, suggesting that microbial dysbiosis were existed in the process of periodontitis (<xref ref-type="bibr" rid="B29">Lin et&#xa0;al., 2020</xref>).</p>
<p>Using LEfSe analysis, we identified differentially abundant genera associated with different diseases. In the present study,periodontitis group had a higher abundance of <italic>Desulfovibrio</italic>, <italic>Filifactor</italic>, <italic>Fretibacterium</italic>, <italic>Moraxella</italic>, <italic>Odoribacter</italic>, <italic>Pseudoramibacter</italic>, <italic>Pyramidobacter</italic>, <italic>Scardovia</italic>, <italic>Shuttleworthia</italic> and <italic>Treponema</italic> in the two types of samples. <italic>Pseudoramibacter, Pyramidobacter, Scardovia, Shuttleworthia</italic> and <italic>Desulfovibrio</italic> have been recognized as periodontitis-associated genera (<xref ref-type="bibr" rid="B10">Colombo et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B19">Huynh et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B41">Shi et&#xa0;al., 2018</xref>). <italic>Treponema denticola</italic>, <italic>Porphyromonas gingivalis</italic>, and <italic>Tannerella forsythia</italic> have been designated as &#x2018;red-complex&#x2019; periopathogens and have shown a strong association with periodontitis (<xref ref-type="bibr" rid="B12">Darveau, 2010</xref>). . It has been reported that patients with COPD tend to have relatively higher ranked means of <italic>Treponema denticola</italic> than healthy participants (<xref ref-type="bibr" rid="B50">Zhou et&#xa0;al., 2020</xref>). The COPD group had a higher abundance of <italic>Mogibacterium</italic> in both sample types. The abundance of <italic>Abiotrophia, Atopobium, Gemella</italic> and <italic>Phocaeicola</italic> also increased in SP samples. In the previous studies, <italic>Abiotrophia</italic>, <italic>Atopobium</italic>, <italic>Mogibacterium</italic> and <italic>Phocaeicola</italic> were common periodontitis-associated genera (<xref ref-type="bibr" rid="B35">Mikkelsen et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B6">Camelo-Castillo et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B49">Zhang et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B11">Coretti et&#xa0;al., 2017</xref>). Besides, we found that no study has adequately described the connection and characteristics of these genera in patients with COPD; <italic>Mogibacterium</italic> is associated with persistent generalized disease (<xref ref-type="bibr" rid="B36">Nibali et&#xa0;al., 2020</xref>). . Patients in the P_COPD group had high proportions of the genera <italic>Anaeroglobus, Bifidobacterium</italic> and <italic>Clostridium</italic> in SP samples and <italic>Phocaeicola</italic> and <italic>Schwartzia</italic> in the GCF samples. <italic>Phocaeicola</italic> and <italic>Schwartzia</italic> have been previously identified in periodontitis (<xref ref-type="bibr" rid="B6">Camelo-Castillo et&#xa0;al., 2015</xref>). <italic>Bergeyella</italic>, <italic>Lautropia</italic>, <italic>Rothia</italic>, <italic>Propionibacterium</italic> and <italic>Cardiobacterium</italic> were more abundant in the healthy participants. <italic>Bergeyella</italic> was considered as putative periodontal protectors in periodontal swabs from the participants (<xref ref-type="bibr" rid="B51">Zorina et&#xa0;al., 2014</xref>). <italic>Lautropia mirabilis</italic>, <italic>Propionibacterium propionicum</italic>, <italic>Rothia dentocariosa/mucilagenosa</italic> and <italic>Cardiobacterium hominis</italic> were significantly more prevalent in the healthy group than in the periodontitis patients (<xref ref-type="bibr" rid="B10">Colombo et&#xa0;al., 2009</xref>; <xref ref-type="bibr" rid="B20">Ikeda et&#xa0;al., 2020</xref>).</p>
<p>This study and observed the association between genera and blood routine indicators. The inflammatory mediators produced by pathogenic microorganisms promote the development of periodontal inflammation and enter the systemic blood circulation, which affects the inflammatory development of systemic diseases (<xref ref-type="bibr" rid="B26">Kumar, 2017</xref>). Here we explored the association between genera and blood routine indicators. <italic>Anaeroglobus geminatus</italic> is positively correlated with different lipid mediators which are related to the inflammatory process of periodontitis (<xref ref-type="bibr" rid="B27">Lee et&#xa0;al., 2021</xref>). We also observed that the relative abundance of <italic>Anaeroglobus</italic> was positively correlated with lymphocyte counts, indicating that dysbiosis of periodontal-associated microorganisms may accelerate the process of inflammatory between periodontitis and COPD. In our study, the relative abundance of <italic>Treponema</italic> and <italic>Filifactor</italic> were significantly increased in periodontitis group. The relative abundance of <italic>Treponema</italic> was positively correlated with neutrophil counts in GCF samples. In the previous study, <italic>Filifactor, Treponema, and Fretibacterium</italic>, which were more abundant in patients with periodontitis, were proved connected with inflammatory mediators (<xref ref-type="bibr" rid="B31">Lundmark et&#xa0;al., 2019</xref>). <italic>Treponema</italic> sp. and cytokines chitinase 3-like 1, sIL-6R&#x3b1;, sTNF-R1, and gp130/sIL-6R&#x3b2; were positively correlated, a negative correlation was identified between IL-10 and <italic>Filifactor alocis</italic>. We discovered that the relative abundance of <italic>Streptococcus</italic> and <italic>Rothia</italic> was negatively correlated with the neutrophil percentages in the GCF samples. In previous study, as a common microorganism of the oral cavity, the presence of <italic>Rothia mucilaginosa</italic> in the lower airways potentially mitigates inflammation (<xref ref-type="bibr" rid="B39">Rigauts et&#xa0;al., 2022</xref>). The levels of <italic>Rothia</italic> and <italic>Streptococcus</italic> were significantly lower in oropharyngeal microbiota composition, in both the COVID-19 and flu patients than in the healthy control group, which indicated oropharyngeal microbiota composition may influence the severity of the disease and the progression of inflammation (<xref ref-type="bibr" rid="B32">Ma et&#xa0;al., 2021</xref>).The results of our study were similar to previous studies, which partly proved that alterations of periodontal-associated microorganisms may impact the progression of inflammation in respiratory disorders, and indicated that the specific high-abundance bacteria in the four groups may have vital clinical significance for the early diagnosis and treatment of periodontitis and COPD.</p>
<p>The differences in metabolic pathways and functions caused by alteration of microbiota were evident in the SP samples. We performed functional predictions based on the KEGG database. Genetic information processing and translation were significantly different between the periodontitis, COPD, and P_COPD groups. It is worth noting that the functions related to bacteria proliferation were higher in these groups. This may partly explain the higher diversity and density of patients with periodontitis and COPD (<xref ref-type="bibr" rid="B40">Shi et&#xa0;al., 2021</xref>). The metabolism of cofactors and vitamins was significantly enriched in the periodontitis and P_COPD groups. Nicotinate and nicotinamide metabolism is associated with the important metabolic pathways in the keystone periodontal pathogen, <italic>Porphyromonas gingivalis </italic>(<xref ref-type="bibr" rid="B18">Hutcherson et&#xa0;al., 2016</xref>). Thiamine is essential for several important enzymes involved in carbohydrate metabolism and associated with the key nutrient for <italic>Treponema denticola</italic> survival (<xref ref-type="bibr" rid="B4">Bian et&#xa0;al., 2015</xref>). The metabolism of glutathione, phosphonate and phosphinate was significantly decreased in the periodontitis, COPD, and P_COPD groups similar to observations from previous studies. Glutathione is an antioxidant that can moderate host cell damage and reduce inflammatory response (<xref ref-type="bibr" rid="B16">Ghezzi, 2011</xref>). <italic>Treponema denticola</italic> is connected to the catabolism of glutathione to H2S (<xref ref-type="bibr" rid="B9">Chu et&#xa0;al., 2020</xref>) and the diseased periodontal pockets of periodontitis patients have lower glutathione levels than healthy sites. Glutathione metabolism may be a key pathway for inflammatory damage in COPD.</p>
<p>This study had several limitations. First, compared to the healthy and periodontitis groups, fewer female individuals were recruited for the COPD, and P_COPD groups because of the difficulty in recruiting older female individuals with COPD. Second, this study was not a longitudinal study which limited the exploration of variations in the oral microbiota during disease progression. Then, the detectable microbial diversity is limited in our sample types, we used 16S rRNA gene amplification which limited our ability to identify specific bacteria at the species level. We will refine this in subsequent studies. Finally, the lower airway microbiota samples were not collected in this study. Studies on association between periodontal bacteria and bacteria in the lower airway are insufficient.</p>
</sec>
<sec id="s5" sec-type="conclusion">
<label>5</label>
<title>Conclusion</title>
<p>The present study discovered that the presence of periodontitis and COPD altered the compositions and functional characterization of oral microbiomes. These diversities in microecology were correlated with the pathological change in diseases. These results may have vital clinical significance in the screening and treatment of individuals with periodontitis and COPD.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: NCBI, BioProject ID: PRJNA910319.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The present study was approved by the ethics committee of Linfen Central Hospital (Ethics Approval No. 2021-42-1) and was performed in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to clinical data collection and sampling.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>SL, YHo and ZG designed the research project. GX, MC, YZ, QC and YQ practiced sample collection. SL, XM, JX and MJ performed DNA extraction and sequencing data analysis. SG, YHo and ZG conducted experiments and contributed significantly to analysis and manuscript preparation. SL, YHe and WY performed the data analyses and wrote the manuscript. XC, WM and NL helped perform the analysis with constructive discussions. All authors contributed to manuscript revision, read, and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>This study was partially supported by Clinical and molecular mechanisms of the dynamic evolution of chronic obstructive pulmonary disease and asthma (No. 2021157), Clinical Medical Research Center of Linfen Central Hospital, Key Medical Research Project of Shanxi Province (No. 2021XM19), and Key Research and Development Plan of Linfen Science and technology (No. 2111).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank the Linfen Central Hospital for assistance with samples and data collection.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2023.1121399/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2023.1121399/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnes</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Burney</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Silverman</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Celli</surname> <given-names>B. R.</given-names>
</name>
<name>
<surname>Vestbo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wedzicha</surname> <given-names>J. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>a). <article-title>Chronic obstructive pulmonary disease</article-title>. <source>Nat. Rev. Dis. Primers</source> <volume>1</volume>, <fpage>15076</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrdp.2015.76</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnes</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Burney</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Silverman</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Celli</surname> <given-names>B. R.</given-names>
</name>
<name>
<surname>Vestbo</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Wedzicha</surname> <given-names>J. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>b). <article-title>Chronic obstructive pulmonary disease</article-title>. <source>Nat. Rev. Dis. Primers</source> <volume>1</volume>, <fpage>1</fpage>&#x2013;<lpage>21</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrdp.2015.76</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bassis</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Erb-Downward</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Dickson</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Freeman</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Young</surname> <given-names>V. B.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Analysis of the upper respiratory tract microbiotas as the source of the lung and gastric microbiotas in healthy individuals</article-title>. <source>Mbio</source> <volume>6</volume> (<issue>2</issue>), <elocation-id>10</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.00037-15</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bian</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Tu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X. Y.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Evidence that TP_0144 of treponema pallidum is a thiamine-binding protein</article-title>. <source>J. Bacteriol.</source> <volume>197</volume> (<issue>7</issue>), <fpage>1164</fpage>&#x2013;<lpage>1172</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.02472-14</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Structure and function of oral microbial community in periodontitis based on integrated data</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2021.663756</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Camelo-Castillo</surname> <given-names>A. J.</given-names>
</name>
<name>
<surname>Mira</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Pico</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nibali</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Henderson</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Donos</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Subgingival microbiota in health compared to periodontitis and the influence of smoking</article-title>. <source>Front. Microbiol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2015.00119</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caramori</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Casolari</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Barczyk</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Durham</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Di Stefano</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Adcock</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>COPD immunopathology</article-title>. <source>Semin. Immunopathol.</source> <volume>38</volume> (<issue>4</issue>), <fpage>497</fpage>&#x2013;<lpage>515</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00281-016-0561-5</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chowdhry</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Sahu</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>Tripathi</surname> <given-names>R. K.</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Singh</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>16S rRNA long-read sequencing of the granulation tissue from nonsmokers and smokers-severe chronic periodontitis patients</article-title>. <source>BioMed. Res. Int.</source> <volume>2018</volume>, <elocation-id>4832912</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2018/4832912</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Phillips</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kolodrubetz</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Glutathione catabolism by treponema denticola impacts its pathogenic potential</article-title>. <source>Anaerobe</source> <volume>62</volume>, <elocation-id>102170</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.anaerobe.2020.102170</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Colombo</surname> <given-names>A. P.</given-names>
</name>
<name>
<surname>Boches</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Cotton</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Goodson</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Kent</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Haffajee</surname> <given-names>A. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2009</year>). <article-title>Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray</article-title>. <source>J. Periodontol.</source> <volume>80</volume> (<issue>9</issue>), <fpage>1421</fpage>&#x2013;<lpage>1432</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1902/jop.2009.090185</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coretti</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Cuomo</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Florio</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Palumbo</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Keller</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Pero</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Subgingival dysbiosis in smoker and non&#x2212;smoker patients with chronic periodontitis</article-title>. <source>Mol. Med. Rep.</source> <volume>15</volume> (<issue>4</issue>), <fpage>2007</fpage>&#x2013;<lpage>2014</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3892/mmr.2017.6269</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Darveau</surname> <given-names>R. P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Periodontitis: A polymicrobial disruption of host homeostasis</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>8</volume> (<issue>7</issue>), <fpage>481</fpage>&#x2013;<lpage>490</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro2337</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dewhirst</surname> <given-names>F. E.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Izard</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Paster</surname> <given-names>B. J.</given-names>
</name>
<name>
<surname>Tanner</surname> <given-names>A. C. R.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>W. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2010</year>). <article-title>The human oral microbiome</article-title>. <source>J. Bacteriol.</source> <volume>192</volume> (<issue>19</issue>), <fpage>5002</fpage>&#x2013;<lpage>5017</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jb.00542-10</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Douglas</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Maffei</surname> <given-names>V. J.</given-names>
</name>
<name>
<surname>Zaneveld</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Yurgel</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>Brown</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>C. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>PICRUSt2 for prediction of metagenome functions</article-title>. <source>Nat. Biotechnol.</source> <volume>38</volume> (<issue>6</issue>), <fpage>685</fpage>&#x2013;<lpage>688</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41587-020-0548-6</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaeckle</surname> <given-names>N. T.</given-names>
</name>
<name>
<surname>Pragman</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Pendleton</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Baldomero</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Criner</surname> <given-names>G. J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The oral-lung axis: The impact of oral health on lung health</article-title>. <source>Respir. Care</source> <volume>65</volume> (<issue>8</issue>), <fpage>1211</fpage>&#x2013;<lpage>1220</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4187/respcare.07332</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghezzi</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Role of glutathione in immunity and inflammation in the lung</article-title>. <source>Int. J. Gen. Med.</source> <volume>4</volume>, <fpage>105</fpage>&#x2013;<lpage>113</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/ijgm.S15618</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes-Filho</surname> <given-names>I. S.</given-names>
</name>
<name>
<surname>Passos</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>Seixas da Cruz</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Respiratory disease and the role of oral bacteria</article-title>. <source>J. Oral. Microbiol.</source> <volume>2</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3402/jom.v2i0.5811</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hutcherson</surname> <given-names>J. A.</given-names>
</name>
<name>
<surname>Gogeneni</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Yoder-Himes</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Hendrickson</surname> <given-names>E. L.</given-names>
</name>
<name>
<surname>Hackett</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Whiteley</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Comparison of inherently essential genes of porphyromonas gingivalis identified in two transposon-sequencing libraries</article-title>. <source>Mol. Oral. Microbiol.</source> <volume>31</volume> (<issue>4</issue>), <fpage>354</fpage>&#x2013;<lpage>364</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/omi.12135</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huynh</surname> <given-names>H. T. T.</given-names>
</name>
<name>
<surname>Pignoly</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Drancourt</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Aboudharam</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A new methanogen &#x201c;Methanobrevibacter massiliense&#x201d; isolated in a case of severe periodontitis</article-title>. <source>BMC Res. Notes</source> <volume>10</volume> (<issue>1</issue>), <fpage>657</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13104-017-2980-3</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ikeda</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Shiba</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Ikeda</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Suda</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Nakasato</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Takeuchi</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Japanese Subgingival microbiota in health vs disease and their roles in predicted functions associated with periodontitis</article-title>. <source>Odontology</source> <volume>108</volume> (<issue>2</issue>), <fpage>280</fpage>&#x2013;<lpage>291</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10266-019-00452-4</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jakubovics</surname> <given-names>N. S.</given-names>
</name>
<name>
<surname>Kolenbrander</surname> <given-names>P. E.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>The road to ruin: the formation of disease-associated oral biofilms</article-title>. <source>Oral. Dis.</source> <volume>16</volume> (<issue>8</issue>), <fpage>729</fpage>&#x2013;<lpage>739</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1601-0825.2010.01701.x</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jia</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Zhi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Lai</surname> <given-names>P. F. H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>The oral microbiota - a mechanistic role for systemic diseases</article-title>. <source>Br. Dent. J.</source> <volume>224</volume> (<issue>6</issue>), <fpage>447</fpage>&#x2013;<lpage>455</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.bdj.2018.217</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiao</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Jing</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Si</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Tai</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The prevalence and severity of periodontal disease in mainland China: Data from the fourth national oral health survey, (2015-2016)</article-title>. <source>J. Clin. Periodontol.</source> <volume>48</volume> (<issue>2</issue>), <fpage>168</fpage>&#x2013;<lpage>179</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcpe.13396</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kinane</surname> <given-names>D. F.</given-names>
</name>
<name>
<surname>Stathopoulou</surname> <given-names>P. G.</given-names>
</name>
<name>
<surname>Papapanou</surname> <given-names>P. N.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Periodontal diseases</article-title>. <source>Nat. Rev. Dis. Primers</source> <volume>3</volume>, <fpage>17038</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrdp.2017.38</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kucukcoskun</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Baser</surname> <given-names>U.</given-names>
</name>
<name>
<surname>Oztekin</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Kiyan</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Yalcin</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Initial periodontal treatment for prevention of chronic obstructive pulmonary disease exacerbations</article-title>. <source>J. Periodontol.</source> <volume>84</volume> (<issue>7</issue>), <fpage>863</fpage>&#x2013;<lpage>870</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1902/jop.2012.120399</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>P. S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>From focal sepsis to periodontal medicine: a century of exploring the role of the oral microbiome in systemic disease</article-title>. <source>J. Physiol.</source> <volume>595</volume> (<issue>2</issue>), <fpage>465</fpage>&#x2013;<lpage>476</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1113/jp272427</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>C. T.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Tribble</surname> <given-names>G. D.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>W. J.</given-names>
</name>
<name>
<surname>Ferguson</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Subgingival microbiome and specialized pro-resolving lipid mediator pathway profiles are correlated in periodontal inflammation</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.691216</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>B. Z.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H. Y.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W. J.</given-names>
</name>
<name>
<surname>Tao</surname> <given-names>J. H.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>N. W.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Dysbiosis of oral microbiota is associated with systemic lupus erythematosus</article-title>. <source>Arch. Oral. Biol.</source> <volume>113</volume>, <elocation-id>10</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.archoralbio.2020.104708</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Han</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Saliva microbiome changes in patients with periodontitis with and without chronic obstructive pulmonary disease</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.00124</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Salivary microbiome profile of diabetes and periodontitis in a Chinese population</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.933833</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lundmark</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y. O. O.</given-names>
</name>
<name>
<surname>Huss</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Johannsen</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Andersson</surname> <given-names>A. F.</given-names>
</name>
<name>
<surname>Yucel-Lindberg</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Identification of salivary microbiota and its association with host inflammatory mediators in periodontitis</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2019.00216</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Ge</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Gan</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Metagenomic analysis reveals oropharyngeal microbiota alterations in patients with COVID-19</article-title>. <source>Signal Transduct Target Ther.</source> <volume>6</volume> (<issue>1</issue>), <fpage>191</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41392-021-00614-3</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Malczynski</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zembower</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Qi</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Diagnostic performance of ion 16S metagenomics kit and ion reporter metagenomics workflow for bacterial pathogen detection in culture-negative clinical specimens from sterile sources</article-title>. <source>Diagn. Microbiol. Infect. Dis.</source> <volume>101</volume> (<issue>2</issue>), <elocation-id>115451</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2021.115451</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mammen</surname> <given-names>M. J.</given-names>
</name>
<name>
<surname>Sethi</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>COPD and the microbiome</article-title>. <source>Respirology</source> <volume>21</volume> (<issue>4</issue>), <fpage>590</fpage>&#x2013;<lpage>599</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/resp.12732</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikkelsen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Theilade</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Poulsen</surname> <given-names>K.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Abiotrophia species in early dental plaque</article-title>. <source>Oral. Microbiol. Immunol.</source> <volume>15</volume> (<issue>4</issue>), <fpage>263</fpage>&#x2013;<lpage>268</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1034/j.1399-302x.2000.150409.x</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nibali</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Sousa</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Davrandi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Spratt</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Alyahya</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Dopico</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Differences in the periodontal microbiome of successfully treated and persistent aggressive periodontitis</article-title>. <source>J. Clin. Periodontol.</source> <volume>47</volume> (<issue>8</issue>), <fpage>980</fpage>&#x2013;<lpage>990</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jcpe.13330</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Preshaw</surname> <given-names>P. M.</given-names>
</name>
<name>
<surname>Alba</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Herrera</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Jepsen</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Konstantinidis</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Makrilakis</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Periodontitis and diabetes: a two-way relationship</article-title>. <source>Diabetologia</source> <volume>55</volume> (<issue>1</issue>), <fpage>21</fpage>&#x2013;<lpage>31</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00125-011-2342-y</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rabe</surname> <given-names>K. F.</given-names>
</name>
<name>
<surname>Watz</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Chronic obstructive pulmonary disease</article-title>. <source>Lancet</source> <volume>389</volume> (<issue>10082</issue>), <fpage>1931</fpage>&#x2013;<lpage>1940</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(17)31222-9</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rigauts</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Aizawa</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Rogers</surname> <given-names>G. B.</given-names>
</name>
<name>
<surname>Govaerts</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Cos</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease</article-title>. <source>Eur. Respir. J.</source> <volume>59</volume> (<issue>5</issue>). doi:&#xa0;<pub-id pub-id-type="doi">10.1183/13993003.01293-2021</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Xun</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Metagenomic analysis of the salivary microbiota in patients with caries, periodontitis and comorbid diseases</article-title>. <source>J. Dent. Sci.</source> <volume>16</volume> (<issue>4</issue>), <fpage>1264</fpage>&#x2013;<lpage>1273</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.jds.2020.12.002</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Nie</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>The subgingival microbiome of periodontal pockets with different probing depths in chronic and aggressive periodontitis: A pilot study</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>8</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2018.00124</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slocum</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Kramer</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Genco</surname> <given-names>C. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Immune dysregulation mediated by the oral microbiome: potential link to chronic inflammation and atherosclerosis</article-title>. <source>J. Intern. Med.</source> <volume>280</volume> (<issue>1</issue>), <fpage>114</fpage>&#x2013;<lpage>128</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/joim.12476</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Pan</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Relationship among clinical periodontal, microbiologic parameters and lung function in participants with chronic obstructive pulmonary disease</article-title>. <source>J. Periodontol.</source> <volume>90</volume> (<issue>2</issue>), <fpage>134</fpage>&#x2013;<lpage>140</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jper.17-0705</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Minty</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Vinel</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Canceill</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Loubieres</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Burcelin</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Oral microbiota: A major player in the diagnosis of systemic diseases</article-title>. <source>Diagnostics</source> <volume>11</volume> (<issue>8</issue>), <fpage>29</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/diagnostics11081376</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tonetti</surname> <given-names>M. S.</given-names>
</name>
<name>
<surname>Greenwell</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Kornman</surname> <given-names>K. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Staging and grading of periodontitis: Framework and proposal of a new classification and case definition</article-title>. <source>J. Periodontol.</source> <volume>89</volume>, <fpage>S159</fpage>&#x2013;<lpage>S172</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/jper.18-0006</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vogelmeier</surname> <given-names>C. F.</given-names>
</name>
<name>
<surname>Criner</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Martinez</surname> <given-names>F. J.</given-names>
</name>
<name>
<surname>Anzueto</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Barnes</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Bourbeau</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>195</volume> (<issue>5</issue>), <fpage>557</fpage>&#x2013;<lpage>582</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201701-0218PP</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ward</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Larson</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Meulemans</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hillmann</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Lynch</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sidiropoulos</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>BugBase predicts organism-level microbiome phenotypes</article-title>. <source>bioRxiv</source> <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1101/133462</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname> <given-names>Z. S.</given-names>
</name>
<name>
<surname>Xiao</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F. H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Z. D.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Pulmonary disease and periodontal health: a meta-analysis</article-title>. <source>Sleep Breathing</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11325-022-02577-3</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Qin</surname> <given-names>X. Y.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>W. P.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>X. L.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Comparison of subgingival and peri-implant microbiome in chronic periodontitis</article-title>. <source>Chin. J. Dent. Res.</source> <volume>18</volume> (<issue>3</issue>), <fpage>155</fpage>&#x2013;<lpage>162</lpage>.</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Song</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Periodontal status and microbiologic pathogens in patients with chronic obstructive pulmonary disease and periodontitis: A case-control study</article-title>. <source>Int. J. Chron Obstruct Pulmon Dis.</source> <volume>15</volume>, <fpage>2071</fpage>&#x2013;<lpage>2079</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2147/copd.S266612</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zorina</surname> <given-names>O. A.</given-names>
</name>
<name>
<surname>Petrukhina</surname> <given-names>N. B.</given-names>
</name>
<name>
<surname>Basova</surname> <given-names>A. A.</given-names>
</name>
<name>
<surname>Shibaeva</surname> <given-names>A. V.</given-names>
</name>
<name>
<surname>Trubnikova</surname> <given-names>E. V.</given-names>
</name>
<name>
<surname>Shevelev</surname> <given-names>A. B.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Identification of key markers of normal and pathogenic microbiota determining health of periodontium by NGS-sequencing 16S-rDNA libraries of periodontal swabs</article-title>. <source>Stomatologiia (Mosk)</source> <volume>93</volume> (<issue>6</issue>), <fpage>25</fpage>&#x2013;<lpage>31</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.17116/stomat201493625-31</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>